Here’s a breakdown of the vaccination campaign in Extremadura,Spain,as detailed in the โขtext,categorized for clarity:
1. influenza (flu) Vaccination
* โ Global โfor Seniors: Offered to all individuals 60 years and older in extremadura – aโ first for an autonomous community โขin Spain.โ This aimsโ to prevent hospitalizationsโ and serious illness.
* Expanded Childhood Cohort: Recommended for children aged 6 months to Januaryโค 1,โ 2020 (previously a narrower age range).
* โฃ Vaccine Type (Children):
* โ 6-23 months: Vaxigrip (intramuscular injection)
* 24 months – โJanuary 1,2020:โ Fluenz (intranasal โspray)โ – preferred for better mucosal immunity and โeasier acceptance.
* Goal (Childhood): โReduce infections, school absences, and parental workโ leave.
* โฃ Other Groups: Also offered to peopleโ with chronic โคdiseases,โ pregnant women, cohabitants of immunosuppressedโ individuals, and โขhealthcare/social care workers exposedโข toโข animals.
2. COVID-19 Vaccination
* Target Age: Recommended from age 70, due to decreased circulation and concentrated serious illnessโ in older adults.
* High-Risk groups: People with transplant history,immunosuppression,seriousโ chronic diseases,pregnant women,residentsโ of social health โcenters,healthcare personnel,and cohabitantsโข of vulnerable individuals.
* Timing: Available any โคtimeโ of the โyear, withโข a minimum ofโ 3 months since the last doseโค or infection.
* โ Vaccines Available:
* Comirnaty (Pfizer) – adult doses, adapted toโ current strains.
โ * Pediatric and mini-pediatric doses of Comirnaty.
โฃ * โฃ Bimervaxโข (Hipra) – protein vaccine.
* โข โค Doses Available: โฃ115,000 adult, 1,050 pediatric, 400โ mini-pediatric,โค and 16,680โฃ protein โคdoses.
* โ Location: โ Localโ healthโข center,clinic,or nearest centerโค for mutual members.
3. RSV (Respiratory Syncytial โVirus) Vaccination
* โฃ First-Time Implementation: Extremadura is pioneering thisโ vaccination.
* Target Groups:
โค โ * โ Individuals 60 and over institutionalized โขin nursing homes.
โค โ* โ People with lung transplants.
* โโฃ Goal: โฃReduce morbidity and mortality fromโ RSV in โขvulnerable adults.
* โ Timing: Begins in November.
* Doses: โ15,000 doses acquired (investment โof โalmost โฌ2 million).
Keyโ Highlights & Overall Campaign Focus
* pioneering Approach: Extremadura isโข positioning itself as a leader in respiratoryโ disease prevention.
* โค Investment: โ Nearly โคโฌ6 million invested in the campaign.
* โ Accessibility: Efforts to improve coverage โขand facilitate accessโ to vaccines.
* coordinated Strategy: โขAโข comprehensive plan usingโ adapted vaccines.
* Focus on Vulnerable Populations: โข Prioritizing the health of seniors, those withโข chronic conditions, and immunocompromised individuals.